Coronavirus disease 2019 (COVID-19) monoclonal antibody treatments & products

Medicare Part B (Medical Insurance) covers FDA-authorized or -approved COVID-19 monoclonal antibody treatments and products if you have COVID-19 symptoms.

Your costs in Original Medicare

You pay nothing for a monoclonal antibody treatment when you get it from a Medicare provider or supplier. You must meet certain conditions to qualify. If you're in a Medicare Advantage Plan, check with your plan about your coverage and costs.

Note

Certain FDA-authorized or -approved monoclonal antibody products can protect you before you’re exposed to COVID-19. If you have Part B and your doctor or other health care provider decides this type of product could work for you (like if you have a weakened immune system), you pay nothing when you get the product from a Medicare provider or supplier.

What it is

COVID-19 monoclonal antibody treatments and products can help you fight mild to moderate COVID-19 and keep you out of the hospital. This treatment involves an infusion of monoclonal antibodies (specifically bamlanivimab, or casirivimab and imdevimab) to treat COVID-19. Health care providers can only give the infusions in certain settings.

Things to know

Medicare also covers COVID-19 diagnostic tests, COVID-19 antibody tests, and COVID-19 vaccines.

Related resources

Center for Disease Control’s response to COVID-19